Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients (Fit2ThriveMB)

28 de septiembre de 2026 actualizado por: Siobhan M Phillips, Northwestern University

The purpose of this study is to examine which of four components of a digital health intervention using an App and Fitbit meaningfully contribute to increased physical activity in Metastatic Breast Cancer Patients.

Participants will be asked to:

  • Wear a Fitbit and use an app, use 0 to 3 other components for 24 weeks and attend 6 or 12 coaching coaching calls in the first 12 weeks to increase daily steps.
  • Complete a questionnaire at baseline, week 12 and week 24
  • Complete functional performance test (FPT) via Zoom at baseline, week 12 and week 24
  • Wear a research activity monitor (Accelerometer) for 7 days at baseline, week 12 and week 24

Descripción general del estudio

Descripción detallada

Multiphase Optimization Strategy (MOST) methodology will be used to determine which intervention components or component combinations optimally increase daily steps in a 12-week intervention with a 12-week follow-up. MOST is a framework adapted from engineering that uses highly efficient factorial experiments to evaluate individual, and combined, effects of intervention components to determine which ones can be reduced, eliminated, or replaced to improve efficiency. Insufficiently active people with metastatic breast cancer (MBC) will receive a core intervention consisting of the FIt2ThriveMB app and Fitbit and be randomly assigned to four components, each with two-levels, under consideration for inclusion in the optimized intervention: 1) EHR-integration (on v. off); 2) coaching dose (weekly v. bi-weekly; 3) social+ (on v. off) and 4) goal-setting type (highly tailored v. static). The effects of increasing PA on symptom burden, other intensity activities (i.e. moderate to vigorous, light and sedentary), and functional performance and potential mediators and moderators of component effects will also be examined. Knowledge gained from this study will inform the development of more effective and scalable interventions to improve health and disease outcomes in this population.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

224

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Illinois
      • Chicago, Illinois, Estados Unidos, 60611
        • Northwestern University
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Femenino

Descripción

Inclusion Criteria:

  • Female sex assigned at birth, age 18 years or older
  • Diagnosed with metastatic breast cancer or locally advanced disease not amenable to surgical resection.
  • Self-report engagement in <150 min/week of moderate to vigorous physical activity
  • Ownership of an Android or iPhone with an up-to-date version of the operating system
  • Internet access to complete assessments
  • Fluency in spoken and written English
  • Willingness to obtain medical clearance to participate.

Exclusion Criteria:

  • Untreated brain metastases
  • Breast cancer with metastases to only the axillary lymph nodes.
  • Self-reported absolute contraindications to exercise (i.e., non-ambulatory, acute myocardial infarction, severe cognitive or functional impairment)
  • Currently pregnant or plans to become pregnant
  • Plans to move out of the United States in next 12 months
  • Current enrollment in another dietary or physical activity trial

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación factorial
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: 1- Core, EHR, Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Experimental: 2- Core, EHR, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Experimental: 3- Core, EHR, Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Experimental: 4- Core, EHR, Bi-Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Experimental: 5- Core, EHR, Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Experimental: 6- Core, EHR, Bi-Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Experimental: 7- Core, EHR, Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Experimental: 8- Core, EHR, Bi-Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Experimental: 9- Core, Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Experimental: 10- Core, Bi-Weekly Coaching, Social+, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Experimental: 11- Core, Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Experimental: 12- Core, Bi-Weekly Coaching, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Experimental: 13- Core, Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Experimental: 14- Core, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.

Participants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Experimental: 15- Core, Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

Experimental: 16- Core, Bi-Weekly Coaching, Static Goal Setting

The core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.

Participants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.

Participants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Steps
Periodo de tiempo: Baseline, 12 and 24 weeks

The ActiGraph accelerometer will be used. Participants will wear the device during all waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip.

Baseline, 12 and 24 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
ActiGraph measured MVPA
Periodo de tiempo: Baseline, 12 and 24 weeks

Moderate to vigorous physical activity will be measured using the ActiGraph. Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cut points will be used to determine this activity as 2,690-9,642 CPM.

Baseline, 12 and 24 weeks
ActiGraph measured light activity
Periodo de tiempo: Baseline, 12 and 24 weeks

Light intensity physical activity will be measured using the ActiGraph. I Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cutpoints for light activity are defined as Light: 0 - 2,689 CPM.

Baseline, 12 and 24 weeks
ActiGraph measured sedentary behavior
Periodo de tiempo: Baseline, 12 and 24 weeks

Sedentary behavior will be measured using the ActiGraph. Participants will wear the device during waking hours for 7 consecutive days, except when bathing or swimming, on their non-dominant hip. Freedson cutpoints for sedentary behavior are defined as <100 CPM.

Baseline, 12 and 24 weeks
Godin Leisure Time Exercise Questionnaire
Periodo de tiempo: Baseline, 12 and 24 weeks

Participants will be asked to indicate frequency of participation in strenuous (e.g., jogging), moderate (e.g., fast walking), and mild (e.g., easy walking) exercise over the past 7 days and average time spent in each activity. Activity frequencies will be multiplied by 9, 5, and 3 metabolic equivalents, respectively, and summed to create a total leisure time activity score. Weekly minutes of total, light, moderate, and vigorous activity will be calculated by multiplying the frequency and time of each activity. This value will be divided by 7 to obtain daily averages.

Baseline, 12 and 24 weeks
Short Physical Performance Battery (SPPB) Total Score
Periodo de tiempo: Baseline, 12 weeks, 24 weeks

The SPPB score is based on timed measures of gait speed, ability to rise from a chair, and standing balance. Gait speed will be measured using the better of two recorded times over a 4-meter course. Chair stand time will be measured as the time needed to rise five times from a seated position in a chair, with arms folded across the chest. For the balance test, participants will be asked to maintain their feet side-by-side, semi-tandem, and tandem positions for 10 seconds each. Each individual performance measure will be scored according to established cut points and aggregated for a total SPPB score.

Baseline, 12 weeks, 24 weeks
PROMIS Physical Function
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure physical function with 4 items over the past 7 days. Items are combined using a t-score metric where higher score is better.

Baseline, 12 and 24 weeks
PROMIS Anxiety
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Anxiety with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Depression
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Depression with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Fatigue
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Fatigue with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Ability to Participate in Social Roles and Activities
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure Ability to Participate in Social Roles and Activities with 4 items over the past 7 days. Items are combined using a t-score metric where the higher score is better.

Baseline, 12 and 24 weeks
PROMIS Sleep Disturbance
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure sleep disturbance with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Pain Interference
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure pain interference with 4 items over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks
PROMIS Pain Intensity
Periodo de tiempo: Baseline, 12 and 24 weeks

PROMIS-29 (Patient-Reported Outcomes Measurement Information System 29-item Profile) will be used to measure pain intensity with 1 item using a scale 1-10 over the past 7 days. Items are combined using a t-score metric where the lower score is better.

Baseline, 12 and 24 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de enero de 2027

Finalización primaria (Estimado)

1 de enero de 2031

Finalización del estudio (Estimado)

15 de junio de 2031

Fechas de registro del estudio

Enviado por primera vez

18 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

18 de septiembre de 2026

Publicado por primera vez (Actual)

25 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

28 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • STU00224173
  • R01CA305818 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir